Target high-growth sectors Canatu focuses on semiconductor, automotive, and medical diagnostics, with CNT membranes for EUV, film heaters for ADAS, and electrochemical sensors in development. Sales opportunities lie in supplying CNT materials, reactors, and licensing for in-house production across these expanding markets.

Licensing and enabling tech The dual business model — selling CNT products and licensing CNT reactors with Dry Deposition technology — presents a path to enterprise partnerships. Pursue collaboration deals with manufacturers seeking to integrate CNT-based processes without building full R&D capabilities in-house.

Global R&D footprint Headquartered in Finland with operations in the US, Japan, and Taiwan, Canatu has a diverse talent pool and international reach. Opportunities exist to co-develop region-specific solutions and secure multi-region supply agreements for global customers.

Strategic partnerships Canatu emphasizes partnerships with forerunner companies to transform products with nano carbon. Target potential customers who are pursuing advanced materials integration, enabling faster adoption of CNT membranes, film heaters, or sensors in next-gen chips and ADAS solutions.

Financial growth levers With funding of 70M and current revenue under 1M, there is upside for pilot programs, early deployments, and joint go-to-market efforts. Focus on scalable pilots and show ROI through efficiency gains in EUV processing, thermal management, or diagnostic sensing to attract investment and customers.